Back to Search
Start Over
Applying the CHA2DS2-VASc score to predict the risk of future acute coronary syndrome in patients receiving catheter ablation for atrial fibrillation
- Source :
- International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss , Pp 100567- (2020)
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- Objective: It remains unknown whether catheter ablation for atrial fibrillation (AF) reduces future acute coronary syndrome (ACS) risk or whether the CHA2DS2-VASc score has a role in predicting this risk. We aimed to compare very long-term risk of ACS between patients who received catheter ablation to AF or antiarrhythmic medications and controls without AF. Methods: Propensity scores were calculated for each patient and used to assemble a cohort of 787 patients undergoing AF ablation in 2003–2012. Patients were compared to an equal number of AF patients treated with antiarrhythmic medications and a control group without AF. Patients with previous coronary events were excluded. The primary endpoint was ACS occurrence. Results: Baseline clinical characteristics were comparable. After a mean 9.1 ± 3.2-year follow-up, the ablation group had lower incidence of new onset ACS than the medication and non-AF control groups (annual incidence: 0.15%. 0.78%, and 0.35%; with 2.67, 4.16, and 10.44 cases/1000 person-years, respectively; P
Details
- Language :
- English
- ISSN :
- 23529067
- Volume :
- 29
- Issue :
- 100567-
- Database :
- Directory of Open Access Journals
- Journal :
- International Journal of Cardiology: Heart & Vasculature
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.56821ca539814988886e49999eb34f26
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.ijcha.2020.100567